Suven Life Sciences
209.05
-10.61(-4.83%)
Market Cap₹4,558.80 Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D-4.83%
1M-4.67%
6M+79.61%
1Y+48.38%
5Y+319.36%
View Company Insightsright
More news about Suven Life Sciences
13May 25
Suven Life Sciences Issues Convertible Warrants and Reports Q4 FY24 Financial Results
Suven Life Sciences has issued 62 lakh equity convertible warrants at Rs. 134 each to two investment funds. The company's Q4 FY24 results show a 59.70% decrease in revenue to ₹2.70 crore and an increased net loss of ₹43.90 crore. For the full FY24, revenue improved by 49.09% to ₹32.80 crore, but the company still reported a net loss of ₹105.10 crore.
Suven Life Sciences
209.05
-10.61
(-4.83%)
1 Year Returns:+48.38%
Industry Peers
Syngene International
609.45
(-4.31%)
Indegene
575.40
(+0.61%)
Suven Life Sciences
209.05
(-4.83%)
Vimta Labs
728.65
(-2.94%)
Bilcare
84.20
(-4.75%)
Take Solutions
10.43
(-1.97%)
Adeshwar Meditex
17.25
(-10.39%)
Vanta Bioscience
24.26
(+4.98%)